About Cardiovascular Stent
The Advin Cardiovascular Stent is designed to support blocked or narrowed arteries, helping restore healthy blood flow in patients with heart conditions.It is made with high-quality materials that ensure durability, flexibility, and safe placement inside the artery.This stent provides reliable performance during cardiovascular procedures, improving patient outcomes and reducing complications.Advanced Features
-
Strong radial support for effective artery opening
-
Smooth delivery system for accurate placement
-
Flexible design for safe navigation through vessels
-
Biocompatible material to minimize risks
-
Reliable performance for long-term patient outcomes
Flexible and Accurate Vascular SupportThis balloon-expandable cardiovascular stent provides robust support while maintaining flexibility, allowing for precise adaptation to the vessel anatomy. Enhanced radiopacity ensures the stent is clearly visible under fluoroscopy, aiding in accurate placement and minimizing procedural risks. Biocompatible materials further reduce the risk of patient complications.
Ready-to-Use and Safe PackagingEach stent is supplied in a single sterile pack, ensuring immediate readiness for use in clinical interventions. The packaging upholds sterility and simplifies handling, allowing medical teams to focus on patient care without delays. The product's shelf life of 3-5 years ensures long-term storage without compromising device performance.
FAQ's of Cardiovascular Stent:
Q: How is this cardiovascular stent deployed during procedures?
A: The stent is placed using a manual balloon expansion method via an included delivery system. It is compatible with standard 0.014" guidewires, offering precise control and accurate vascular placement during coronary interventions.
Q: What benefits does the enhanced radiopacity provide?
A: Enhanced radiopacity allows the stent to be clearly visible under fluoroscopy. This visual clarity helps clinicians monitor and position the stent precisely within the coronary vessel, ensuring optimal placement and reducing procedural risks.
Q: When should a drug-eluting variant with antithrombotic coating be considered?
A: A drug-eluting, antithrombotic-coated stent may be recommended for patients at higher risk of restenosis or thrombosis. The optional coating helps prevent blood clot formation and reduces the chance of artery re-narrowing after the procedure.
Q: Where should the stents be stored prior to use?
A: Stents should be kept in sterile, dry conditions prior to use. Proper storage ensures preservation of sterility, maintains the device's performance, and upholds its 3-5 year shelf life.
Q: What is the dimensional range of this cardiovascular stent?
A: The stent is available in sizes ranging from 2.0 to 4.0 mm in diameter and 8 to 38 mm in length, allowing clinicians to select the most suitable size for each patient's vascular anatomy.
Q: Is the stent intended for multiple uses?
A: No, the stent is designed for single use only. Reuse can compromise sterility and device integrity, increasing the risk of infection or procedural complications.